Probiomed

Probiomed is a Mexican biopharmaceutical company established in 1970, specializing in the research, development, manufacturing, and commercialization of pharmaceutical products for human health. Operating within the Pharmaceuticals and Healthcare industries, Probiomed focuses on delivering high-technology biopharmaceutical solutions designed to enhance patient health and quality of life globally. The company's strategic objective is to ensure broader access to essential treatments worldwide through its commitment to innovation and quality.

The company's extensive portfolio encompasses a wide array of generic chemical synthesis and biocomparable products. These include critical therapeutic agents such as cytokines, monoclonal antibodies, fusion proteins, and recombinant vaccines, all developed to address significant social and economic health challenges. Probiomed operates with a workforce of 500-1,000 employees and reported revenue of $21.8M. With a single operational location, the company is dedicated to its mission, and you can Meet Probiomed's team to learn more about their leadership and operational structure.

Headquartered in Mexico City, Mexico, Probiomed has consistently worked since its inception to make vital treatments accessible to a global patient base. Their business model emphasizes providing advanced biopharmaceutical solutions that contribute to improved health outcomes. The company's dedication to research and development underpins its ability to offer a diverse range of products aimed at treating complex health conditions and improving overall public health.